• 1-800-781-0477, 1-760-231-9471
  • Email:sales@AmericanPharmaWholesale.com
  • Site Map



Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#,UPC#or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.
Menu

KAPSPARGO SPRINKLE 100 MG ER CAP 30

 Generic Name:
METOPROLOL SUCCINATE

 Description:
KAPSPARGO SPRINKLE ER CP 50MG 30 
 Alt Item #: 
5467840

 NDC:
10631-0009-30

 UPC:
310631-009304
 Contract:

Contract Alias:

Strength:
50MG

 Form: Generic Name:
METOPROLOL SUCCINATE

 Description:
KAPSPARGO SPRINKLE ER CP 50MG 30 
 Alt Item #: 
5467840

 NDC:
10631-0009-30

 UPC:
310631-009304
 Contract:

Contract Alias:

Strength:
50MG

 Form:American Pharma Wholesale, Your Health Care Place.

KAPSPARGO SPRINKLE 100 MG ER CAP 30

$69.12$66.99

Item No.:RX 10631-0010-30 Generic Name:
METOPROLOL SUCCINATE

Description:
KAPSPARGO SPRINKLE ER CP 50MG 30
Alt Item #:
5467840

NDC:
10631-0009-30

UPC:
310631-009304
Contract:

Contract Alias:

Strength:
50MG

Form:
CAPSULES

Size:
1X30 EA Only Physician,Pharmacy or Licensed Facility can order this Rx Item NDC No.: 10631001030,10631-010-30,1063101030 UPC:310631010300,310631010300

Have a question?

These highlights do not include all the information needed to use KAPSPARGO safely and effectively. See full prescribing information for KAPSPARGO. KAPSPARGO TM Sprinkle (metoprolol succinate) capsules, extended-release, for Oral Use Initial U.S. Approval: 1992 INDICATIONS AND USAGE KAPSPARGO Sprinkle is a beta1-selective adrenoceptor blocking agent indicated for the treatment of: (1) Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) Angina Pectoris. (1.2) Heart Failure, to reduce the risk of cardiovascular mortality and heart-failure hospitalization in patients with heart failure. (1.3) DOSAGE AND ADMINISTRATION Adult Hypertension: Usual initial dosage is 25 to 100 mg once daily. Titrate weekly (or longer) to optimal blood pressure. (2.1) Pediatric Hypertension 6 years of age and older: The recommended starting dose is 1 mg/kg, once daily and titrate to response. Do not exceed a maximum initial dose of 50 mg once daily. (2.1) Angina Pectoris: Usual initial dosage is 100 mg once daily. Titrate weekly based on clinical response. (2.2) Heart Failure: The recommended starting dose is 25 mg once daily doubled every two weeks to the highest dose tolerated or up to 200 mg. (2.3) DOSAGE FORMS AND STRENGTHS KAPSPARGO extended-release capsules: 25 mg, 50 mg, 100 mg and 200 mg. (3) CONTRAINDICATIONS Known hypersensitivity to product components. (4) Severe bradycardia, greater than first degree heart block, or sick sinus syndrome without a pacemaker. (4) Cardiogenic shock or decompensated heart failure. (4) WARNINGS AND PRECAUTIONS Abrupt cessation may exacerbate myocardial ischemia. (5.1) Worsening cardiac failure may occur. (5.2) Bronchospastic Disease: Avoid beta blockers. (5.3) Pheochromocytoma: First initiate therapy with an alpha blocker. (5.4) Avoid initiation of high-dose extended-release metoprolol and do not routinely withdraw chronic beta blocker therapy prior to surgery. (5.5, 6.1) May mask tachycardia occurring with hypoglycemia. (5.6) Abrupt withdrawal in thyrotoxicosis might precipitate a thyroid storm. (5.7) May aggravate symptoms of arterial insufficiency. (5.8) ADVERSE REACTIONS Most common adverse reactions: tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, rash. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Sun Pharmaceutical Industries, Inc. at 1-800-406-7984 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS Catecholamine-depleting drugs may have an additive effect when given with beta-blocking agents. (7.1) Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. (7.2) CYP2D6 Inhibitors are likely to increase metoprolol concentration. (7.3) Concomitant use of glycosides, clonidine, and diltiazem and verapamil with beta-blockers can increase the risk of bradycardia. (7.4) Beta-blockers including metoprolol, may exacerbate the rebound hypertension that can follow the withdrawal of clonidine. (7.4) Alcohol interferes with the extended release properties of this product. (7.5) USE IN SPECIFIC POPULATIONS Hepatic Impairment: Consider initiating metoprolol succinate therapy at low doses and gradually increase dosage to optimize therapy, while monitoring closely for adverse events. (8.6) See 17 for PATIENT COUNSELING INFORMATION. Revised: 5/2018

 Generic Name:
METOPROLOL SUCCINATE

 Description:
KAPSPARGO SPRINKLE ER CP 50MG 30 
 Alt Item #: 
5467840

 NDC:
10631-0009-30

 UPC:
310631-009304
 Contract:

Contract Alias:

Strength:
50MG

 Form:
KAPSPARGO SPRINKLE 100 MG ER CAP 30
Generic Name: METOPROLOL SUCCINATE Description: KAPSPARGO SPRINKLE ER CP 50MG 30 Alt Item #: 5467840 NDC: 10631-0009-30 UPC: 310631-009304 Contract: Contract Alias: Strength: 50MG Form:

 Generic Name:
METOPROLOL SUCCINATE

 Description:
KAPSPARGO SPRINKLE ER CP 50MG 30 
 Alt Item #: 
5467840

 NDC:
10631-0009-30

 UPC:
310631-009304
 Contract:

Contract Alias:

Strength:
50MG

 Form:
Sun Pharma
Generic Name: METOPROLOL SUCCINATE Description: KAPSPARGO SPRINKLE ER CP 50MG 30 Alt Item #: 5467840 NDC: 10631-0009-30 UPC: 310631-009304 Contract: Contract Alias: Strength: 50MG Form:

American Pharma Wholesale, Your Health Care Place.
American Pharma Wholesale
American Pharma Wholesale, Your Health Care Place.